People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cell Microsystems, Inc. | — | Biotechnology | Series A | $21.0M | $52.4M | 2021 |
Deval M. Lashkari at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Deval M. Lashkari on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher Sims | 1 | 5 |
| Gary Pace | 1 | 3 |
| Gary M. Pace | 1 | 1 |
| Christopher M. Sims | 1 | 1 |
| Alexander M. Herzick | 1 | 1 |
| Brett M. Williams | 1 | 1 |
| Nancy Allbritton | 1 | 1 |
| Yuli Wang | 1 | 1 |
| Matthew Megaro | 1 | 1 |
| Rob M. Capone | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.